A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Inhaled CHF6001

Clinical trial NCT02386761 · COMPLETED

Trial details

NCT number: NCT02386761
Sponsor: Chiesi Farmaceutici S.p.A.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease

Start date: 2014-11-01
Primary completion: 2015-05-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.